Why is Nephro Care falling/rising?

As of 24-Sep, Nephro Care India Ltd is currently priced at 142.65, reflecting a slight increase of 0.5 (0.35%). The stock has shown a performance today that outperformed its sector by 0.97%. However, it has experienced a significant decline over the past month, down 18.06%, and a year-to-date drop of 22.47%. Additionally, the stock's delivery volume has decreased by 54.82% compared to the 5-day average, indicating falling investor participation. The stock is currently trading above its 100-day moving average but below its 5-day, 20-day, 50-day, and 200-day moving averages, suggesting mixed signals regarding its recent price movement. There are no positive or negative factors available to further explain the stock's recent performance.
In the broader market context, Nephro Care's short-term return of -6.00% over the past week contrasts sharply with the Sensex, which has only declined by 1.08% during the same period. This underperformance highlights the stock's challenges compared to the benchmark index. Over the past month, while Nephro Care has fallen by 18.06%, the Sensex has managed a slight gain of 0.75%, further emphasizing the stock's struggles in the current market environment. Overall, the combination of declining investor interest and significant underperformance relative to the benchmark suggests a challenging outlook for Nephro Care India Ltd.